All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

24

Reset

24 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BioNTech SE · Influenza, COVID-19, COVID-19 (Coronavirus Disease 2019)

  • GP681Phase 32 trials

    Jiangxi Qingfeng Pharmaceutical Co. Ltd. · Influenza, Human, Influenza

  • GP681 SimulantPhase 32 trials

    Jiangxi Qingfeng Pharmaceutical Co. Ltd. · Influenza, Human, Influenza

  • IIV-HDstandalonePhase 32 trials

    Sanofi · COVID-19 Immunization, Influenza Immunization, Immunization

  • LG Chem · Diphtheria, Tetanus, Pertussis

  • ZSP1273Phase 32 trials

    Guangdong Raynovent Biotech Co., Ltd · Influenza A, Influenza a

  • ADC189Phase 31 trial

    Jiaxing AnDiCon Biotech Co.,Ltd · Influenza Type A, Influenza Type B

  • BK1803Phase 31 trial

    Tanabe Pharma Corporation · Pertussis, Diphtheria, Tetanus

  • BRC-201TG-1000, Pixavir MarboxilPhase 31 trial

    Boryung Biopharma Co., Ltd. · Influenza

  • mRNA-1018-H5Phase 31 trial

    Moderna · Influenza

  • NVXC19EU licensed, standalonePhase 31 trial

    Sanofi · Immunization, Healthy Volunteers, COVID-19 Immunization

  • Flu mRNAGSK6479720A, GSK6498032APhase 22 trials

    GSK · Influenza, Human

  • Fluzone QudrivalentPhase 22 trials

    Sanofi · Healthy Volunteers, Influenza Immunization, Influenza

  • rC19Novavax's adjuvanted recombinant COVID-19Phase 22 trials

    Sanofi · COVID-19 Immunization, Influenza Immunization

  • TRX-100Phase 22 trials

    Traws Pharma, Inc. · Influenza

  • ApomivirFE-L-APO, drug substancePhase 21 trial

    Far East Bio-Tec Co., Ltd · Influenza

  • ARCT-2304Phase 21 trial

    Arcturus Therapeutics, Inc. · Influenza, Human

  • AZD4117Phase 21 trial

    AstraZeneca · Influenza A

  • AZD5315Phase 21 trial

    AstraZeneca · Influenza A

  • DL001ZF2G22B, F2H23HPhase 21 trial

    GSK · Influenza, Human

  • DL001Z-NHF2H23D, F2H23BPhase 21 trial

    GSK · Influenza, Human

  • GSK5800544APhase 21 trial

    GSK · Influenza, Human

  • OVX836Phase 21 trial

    Osivax · Influenza

  • SYH2085Phase 21 trial

    CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Influenza

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.